深圳瑞捷(300977.SZ):近日與國檢集團簽署了《戰略合作框架協議》
格隆匯5月5日丨有投資者在投資者互動平台向深圳瑞捷(300977.SZ)提問,“公司是否與中國國檢測試控股集團股份有限公司(簡稱“國檢集團”)簽訂了合作協議”
深圳瑞捷回覆稱,近日公司與國檢集團簽署了《戰略合作框架協議》,雙方將在工程管理諮詢、第三方工程評估、檢驗檢測、認證、綠建、雙碳等相關業務和培訓開展合作,充分發揮各自在業務、培訓、技術研究等方面的經驗和優勢資源,為雙方合作創造更大的商業價值,打造雙贏、可持續發展的戰略合作伙伴關係,為行業發展作出積極貢獻。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.